Aurora Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,661
Closed -$891K 114
2022
Q2
$891K Buy
3,661
+20
+0.5% +$4.9K 0.64% 90
2022
Q1
$880K Buy
3,641
+121
+3% +$27.8K 0.56% 104
2021
Q4
$792K Sell
3,520
-209
-6% -$44.1K 0.47% 110
2021
Q3
$793K Buy
3,729
+65
+2% +$15K 0.55% 98
2021
Q2
$893K Buy
3,664
+24
+0.7% +$5.9K 0.62% 85
2021
Q1
$906K Buy
+3,640
New +$869K 0.67% 83

Other funds holding AMGN

Aurora Investment Counsel's AMGN Position: Q3 2022 in Review

Aurora Investment Counsel sold out of Amgen (AMGN) in Q3 2022, closing a stake of 3,661 shares — an estimated $891K sold.

Aurora Investment Counsel first reported a position in AMGN in Q1 2021 and held it in 6 quarters. The position peaked at $906K in Q1 2021. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

  • Aurora Investment Counsel reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
  • Aurora Investment Counsel sold 3,661 Amgen shares in Q3 2022, an estimated $891K.
  • Aurora Investment Counsel first reported a position in Amgen in Q1 2021 and held it in 6 quarters.
  • Aurora Investment Counsel's Amgen position peaked at $906K in Q1 2021.
  • 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Aurora Investment Counsel's 13F filing for Q3 2022, filed 23 Nov 2022.